Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Public Health Interest of Kaletra: Impact on Resistance to ARVs - EOLE

NCT01103596 is registered in ClinicalTrials.gov with Abbott as lead sponsor.

NCT NCT01103596
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01103596 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Public Health Interest of Kaletra: Impact on Resistance to ARVs - EOLE
Lead sponsor
Abbott
Phase
Observational
Overall status
Completed
Start date
March 31, 2008
Completion date
July 31, 2009
Enrollment
94 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infection